Clinical Trials in Boston

Showing 8201-8220 of 17,836 trials

Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies

NCT01947140

This is a study to test how safe the combination of the drugs Romidepsin and Pralatrexate are in patients with lymphoid malignancies and to determine the dose of the combination of drugs that is safest. If the combination is determined to be safe, the study will continue accrual patients with peripheral T-Cell lymphoma (PTCL).

Lymphoid MalignanciesMultiple MyelomaLymphoma+2 more

Jennifer Amengual57 participantsStarted Sep 2013

Boston, Massachusetts, United States • New York, New York, United States • Philadelphia, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia

NCT03187262

This research study is studying Daratumumab as a possible treatment for Waldenström Macroglobulinemia.

Waldenström Macroglobulinemia

Dana-Farber Cancer Institute13 participantsStarted Nov 2017

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Rochester, Minnesota, United States +2 more locations

Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies

A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia

Find Trials by Condition in Boston

A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection

Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease

Duloxetine Tibial Plateau

Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors

Shared Decision-making on Medical Tests and Care Cascades

Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

MIPE for Pilonidal Disease

Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)

A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)

THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

Artificial Intelligence for Digital Cholangioscopy Neoplasia Diagnosis

Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD)

Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure

A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)

Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma

Longitudinal Study of Music Therapy's Effectiveness for Premature Infants and Their Caregivers